Market Overview:
The global extracorporeal CO2 removal market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of respiratory diseases, rising geriatric population, and technological advancements in CO2 removal devices. Based on type, the extracorporeal CO2 removal market is segmented into extracorporeal CO2 machines and disposables. The disposables segment is further sub-segmented into filters, cartridges, and bags. Based on application, the market is segmented into hospitals and surgical centers. Geographically, the market is divided into North America, Latin America, Europe Asia Pacific (APAC), and Middle East & Africa (MEA). North America dominates the global extracorporeal CO2 removal market due to early adoption of novel technologies by key players operating in this region coupled with rising incidence of respiratory diseases such as asthma and COPD .
Product Definition:
Extracorporeal CO2 removal is the process of removing carbon dioxide from the blood outside of the body. This can be done through a variety of methods, including hemodialysis, hemofiltration, and adsorption. Extracorporeal CO2 removal is important because it helps to maintain blood pH levels and prevents respiratory acidosis.
Extracorporeal CO2 Machines:
Extracorporeal CO2 machines, also called extracorporeal carbon dioxide removal devices are used to remove carbon dioxide from the blood. The Extracorporeal CO2 Machines are used in patients suffering from conditions such as respiratory acidosis and hypercapnia. In these patients, there is an increased amount of carbon dioxide in the blood resulting in a higher pH level which can damage many parts of the body including kidneys, heart and brain if not treated properly.
Disposables:
Disposables are used in Extracorporeal CO2 Removal (ECCO) devices to prevent infections. They consist of a sterile field and an adhesive layer that allows the skin patch to stick to the body. The disposable is made up of materials such as silicon, hydrogel, or acrylic and has a protective coating on it so that it does not come into direct contact with the patient's skin.
Application Insights:
Based on application, the market is segmented into hospitals and surgical centers. Hospitals held the largest share of over 70.0% in 2017 owing to increasing prevalence of chronic diseases such as heart diseases, hypertension, diabetes mellitus Type 2 and obesity which increases the risk of death after surgery or trauma due to respiratory failure or cardiac arrest.
Extracorporeal membrane oxygenation (ECMO) has been found helpful in treating patients with acute respiratory failure and hypoxic-ischemic encephalopathy post liver transplantation procedures.
Regional Analysis:
Europe dominated the global market in 2017 owing to the increasing prevalence of COVID-19 and other infectious diseases. The region is expected to continue its dominance over the forecast period due to factors such as favorable government initiatives, high healthcare expenditure, and rising awareness about ECMO technologies. Asia Pacific is expected to grow at a lucrative rate during the forecast period due to factors such as improving healthcare infrastructure & facilities along with growing medical tourism in emerging countries of this region. In addition, an increase in birth defects reported from China has also triggered an increase in demand for extracorporeal CO2 removal systems across various hospitals & surgical centers throughout China.
Growth Factors:
- Increasing incidence of respiratory diseases: The increasing incidence of respiratory diseases is one of the key growth drivers for the extracorporeal CO2 removal market. Respiratory diseases are caused due to various factors such as air pollution, smoking, and occupational exposure to dust and fumes. These factors lead to an increase in the levels of CO2 in the blood, which can cause serious health problems. This is where extracorporeal CO2 removal comes into play as it helps in removing excess CO2 from the blood, thus preventing any health complications.
- Rising geriatric population: The global geriatric population is growing at a rapid pace and this is expected to drive demand for extracorporeal CO2 removal devices over the next few years. Elderly people are more prone to respiratory problems due to their weak immune system and this makes them ideal candidates for treatment with these devices. In addition, rising awareness about the benefits of using these devices among elderly people is also contributing towards market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Extracorporeal CO2 Removal Market Research Report
By Type
Extracorporeal CO2 Machines, Disposables
By Application
Hospitals, Surgical Centers
By Companies
ALung Technologies, XENIOS, Medtronic, ESTOR, Medica, Getinge, Aferetica, ALung Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Extracorporeal CO2 Removal Market Report Segments:
The global Extracorporeal CO2 Removal market is segmented on the basis of:
Types
Extracorporeal CO2 Machines, Disposables
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ALung Technologies
- XENIOS
- Medtronic
- ESTOR
- Medica
- Getinge
- Aferetica
- ALung Technologies
Highlights of The Extracorporeal CO2 Removal Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Extracorporeal CO2 Machines
- Disposables
- By Application:
- Hospitals
- Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Extracorporeal CO2 Removal Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Extracorporeal carbon dioxide removal (ECOR) is a process that removes CO2 from the atmosphere by using an external energy source to break down the gas into its component parts. The most common ECOR technology is called thermal oxidization, which uses heat to break down CO2 into water vapor and oxygen.
Some of the major players in the extracorporeal co2 removal market are ALung Technologies, XENIOS, Medtronic, ESTOR, Medica, Getinge, Aferetica, ALung Technologies.
The extracorporeal co2 removal market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Extracorporeal CO2 Removal Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Extracorporeal CO2 Removal Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Extracorporeal CO2 Removal Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Extracorporeal CO2 Removal Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Extracorporeal CO2 Removal Market Size & Forecast, 2020-2028
4.5.1 Extracorporeal CO2 Removal Market Size and Y-o-Y Growth
4.5.2 Extracorporeal CO2 Removal Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Extracorporeal CO2 Machines
5.2.2 Disposables
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Extracorporeal CO2 Removal Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Extracorporeal CO2 Removal Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Extracorporeal CO2 Machines
9.6.2 Disposables
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Extracorporeal CO2 Machines
10.6.2 Disposables
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Extracorporeal CO2 Machines
11.6.2 Disposables
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Extracorporeal CO2 Machines
12.6.2 Disposables
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Extracorporeal CO2 Machines
13.6.2 Disposables
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Extracorporeal CO2 Removal Market: Competitive Dashboard
14.2 Global Extracorporeal CO2 Removal Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ALung Technologies
14.3.2 XENIOS
14.3.3 Medtronic
14.3.4 ESTOR
14.3.5 Medica
14.3.6 Getinge
14.3.7 Aferetica
14.3.8 ALung Technologies
